Financing ·
Stereotaxis raises $12M upfront in convertible note financing, with up to $24M total available
STXSStereotaxis, Inc.
Stereotaxis entered into a Note Purchase Agreement for convertible promissory notes totaling up to $24 million. The initial closing on November 9, 2026, provided $12 million in gross proceeds. Additional draws of up to $12 million are available at the company's option upon satisfying specified conditions. The notes bear a 10% annual interest rate, mature in three years, and convert into common stock at $1.21 per share. Concurrently, the company reported third-quarter revenue of $8.9 million, a 20% increase year-over-year, driven by system sales and recurring disposable revenue. Stereotaxis is a pioneer and global leader in innovative surgical robotics for minimally invasive endovascular intervention.